Evaluation of insulin sensitivity status in polycystic ovarian syndrome

Asian Pacific Journal of Tropical Disease

Volumn 1, Issue 1, 2011, Pages 67-70

  Wilma, Delphine Silvia C ^a   Kavya, N ^b   Kulkarni, Sweta ^b  

^a Sapthagiri Institute of Medical Sciences and Research Center   (India)

^b VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE   (India)

Author keywords

BMI; Hyperglycemia; Insulin sensitivity; Polycystic ovarian syndrome; QUICKI; Waist circumference

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIET RESTRICTION; EARLY INTERVENTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; QUANTITATIVE INSULIN INSENSITIVITY CHECK INDEX; RELIABILITY; RISK FACTOR; SENSITIVITY ANALYSIS; WAIST CIRCUMFERENCE;

EID: 79960276958     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(11)60017-0     Document Type: Article

References (22)

1. Stein IF, Leventhal ML Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynaecol 1935, 29:181-197.
2. Conway GS Hyperinsulinaemia and polycystic ovary syndrome. Hum Fertil 2000, 3:93-95.
3. Legro RS, Kunselman AR, Dodson WC, Dunaif A Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome; a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999, 84:165-169.
4. Zacur HA Polycystic ovarian syndrome, hyperandrogenism, insulin resistance. Obstet Gynaecol Clin North Am 2001, 28:21-23.
5. Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown) 2008, 9(10):987-992.
6. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000, 23:171-175.
7. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G Quantitative Insulin Check Index a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
8. Bhattacharya SM Mathematical indices of insulin resistance and body mass index in polycystic ovarian syndrome. J Obstet Gynecol India 2005, 55:159-162.
9. Roopakala MS, Suresh A, Ashtalakshmi, Srinath, Ashok, Giridhar, et al. Anthropometric measurements as predictors of intraabdominal fat thickness. Indian J Physiol Pharmacol 2009, 53(3):259-264.
10. Carmina E Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Gynecol 2004, 56(1):1-6.
11. Wild S, Pierpoint T, Mc Keigue P, Jacobs H Cardiovascular disease in women with polycystic ovary syndrome at long-term follow up: a restrospective cohort study. Clin Endo Crinol (oxf) 2000, 52:595-600.
12. Unaif A Insulin resistance and polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Res 1997, 18:774-800.
13. Diamanti-Kandarakis E, Papaxastiline AG Molecular mechanisms of insulin resistance in polysystic ovary syndrome. Trends Mol Med 2006, 12:324-334.
14. Cascella T, Palomba S, Sio ID, Manguso F, Giallauria F, Simone BD, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovarian syndrome. Hum Reprod 2007, 16:1-7.
15. Wiwanitkit V Hyperglycemia in poor controlled diabetes from crude tamarind herbal pill: a case study. Asian Pac J Trop Biomed 2011, 1(1):79-80.
16. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, et al. Obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity. J Nutr 2001, 131:354-360.
17. Nestler JE, Powers LP, Matt DW, Matt DW, Steingold KA, Plymate SR, et al. A direct effect of hyperinsulinemia on serum sex hormone binding globulin levels in obese women with PCOS. J Clin Endocrinol Metab 1991, 72:83-89.
18. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ Strategies for the use of insulin-sensitising drugs to treat infertility in women with polycystic ovarian syndrome. Fertil Steril 2002, 77:209-215.
19. Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002, 187:1362-1369.
20. Li M, Youngren JF, Duanif A, Goldfine ID, Maddux BA, Zhang BB, et al. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 2002, 87:4088-4093.
21. Gan SK, Adamandia D, Kriketos, Bronwyn A, Ellis, Campbell H, et al. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 2003, 26:1706-1713.
22. Turner MJ, Walsh J, Byrne KM, Murphy C, Langan H, Farah N Outcome of clinical pregnancies after ovulation induction using metformin. J Obstet Gynaecol 2006, 26(3):233-235.